These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Impaired cardiovascular autonomic function in Parkinson's disease with visual hallucinations. Oka H; Yoshioka M; Onouchi K; Morita M; Mochio S; Suzuki M; Hirai T; Urashima M; Inoue K Mov Disord; 2007 Jul; 22(10):1510-1514. PubMed ID: 17516497 [TBL] [Abstract][Full Text] [Related]
43. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697 [TBL] [Abstract][Full Text] [Related]
45. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy. Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077 [TBL] [Abstract][Full Text] [Related]
46. Retrospective analysis of parkinsonian patients exhibiting normal (123)I-MIBG cardiac uptake. Mizutani Y; Ito S; Murate K; Hirota S; Fukui T; Hikichi C; Ishikawa T; Shima S; Ueda A; Kizawa M; Asakura K; Mutoh T J Neurol Sci; 2015 Dec; 359(1-2):236-40. PubMed ID: 26671120 [TBL] [Abstract][Full Text] [Related]
47. Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease. Masala C; Solla P; Liscia A; Defazio G; Saba L; Cannas A; Cavazzana A; Hummel T; Haehner A J Neurol; 2018 Aug; 265(8):1764-1771. PubMed ID: 29804147 [TBL] [Abstract][Full Text] [Related]
48. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake. Reinhardt MJ; Jüngling FD; Krause TM; Braune S Eur J Nucl Med; 2000 May; 27(5):595-600. PubMed ID: 10853817 [TBL] [Abstract][Full Text] [Related]
49. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. Druschky A; Hilz MJ; Platsch G; Radespiel-Tröger M; Druschky K; Kuwert T; Neundörfer B J Neurol Sci; 2000 Apr; 175(1):3-12. PubMed ID: 10785250 [TBL] [Abstract][Full Text] [Related]
50. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Jain S; Goldstein DS Neurobiol Dis; 2012 Jun; 46(3):572-80. PubMed ID: 22094370 [TBL] [Abstract][Full Text] [Related]
51. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Baba T; Kikuchi A; Hirayama K; Nishio Y; Hosokai Y; Kanno S; Hasegawa T; Sugeno N; Konno M; Suzuki K; Takahashi S; Fukuda H; Aoki M; Itoyama Y; Mori E; Takeda A Brain; 2012 Jan; 135(Pt 1):161-9. PubMed ID: 22287381 [TBL] [Abstract][Full Text] [Related]
53. MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review. Sakakibara R; Tateno F; Kishi M; Tsuyusaki Y; Terada H; Inaoka T Parkinsonism Relat Disord; 2014 Mar; 20(3):267-73. PubMed ID: 24332912 [TBL] [Abstract][Full Text] [Related]
54. [Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation]. Satoh A; Serita T; Tsujihata M Nihon Rinsho; 1997 Jan; 55(1):202-6. PubMed ID: 9014450 [TBL] [Abstract][Full Text] [Related]
55. Decreased heart rate variability in sympathetic dominant states in Parkinson's disease and isolated REM sleep behavior disorder. Suzuki M; Nakamura T; Ohba C; Hatanaka M; Tsuboi T; Hirayama M; Nakatsubo D; Maesawa S; Saito R; Katsuno M Parkinsonism Relat Disord; 2024 Jul; 124():107020. PubMed ID: 38823170 [TBL] [Abstract][Full Text] [Related]
56. 123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations. Valldeoriola F; Gaig C; Muxí A; Navales I; Paredes P; Lomeña F; De la Cerda A; Buongiorno M; Ezquerra M; Santacruz P; Martí MJ; Tolosa E J Neurol; 2011 Jun; 258(6):1126-32. PubMed ID: 21221623 [TBL] [Abstract][Full Text] [Related]
57. Differences in odor identification among clinical subtypes of Parkinson's disease. Iijima M; Kobayakawa T; Saito S; Osawa M; Tsutsumi Y; Hashimoto S; Uchiyama S Eur J Neurol; 2011 Mar; 18(3):425-9. PubMed ID: 20666834 [TBL] [Abstract][Full Text] [Related]
58. Sudomotor and cardiovascular dysfunction in patients with early untreated Parkinson's disease. Asahina M; Mathias CJ; Katagiri A; Low DA; Vichayanrat E; Fujinuma Y; Yamanaka Y; Kuwabara S J Parkinsons Dis; 2014; 4(3):385-93. PubMed ID: 24577504 [TBL] [Abstract][Full Text] [Related]
59. Smell identification in Japanese Parkinson's disease patients: using the odor stick identification test for Japanese subjects. Iijima M; Kobayakawa T; Saito S; Osawa M; Tsutsumi Y; Hashimoto S; Iwata M Intern Med; 2008; 47(21):1887-92. PubMed ID: 18981632 [TBL] [Abstract][Full Text] [Related]
60. Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms. Kim JS; Lee KS; Song IU; Kim YI; Kim SH; You IR; Kim HT J Neurol Sci; 2008 Jul; 270(1-2):122-6. PubMed ID: 18378259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]